Conference Explores Hype And Hope In Communicating Science News
National Cancer Act: Early Promises Were Overstated
Screening Guidelines: When Scientists Can’t Agree, What’s The Press To Do?
Genetic Testing: No Easy Answers To Public Questions
The Cloning Story: How Dolly Made Page 1 And A Physicist Got Air Time
Clinical Trials: Stories On Results Can Have Unintended Consequences
Alternative Medicine: Testing The Boundaries Of Science
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Scaling excellence: How City of Hope is transforming cancer care delivery
- First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI